BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 29737913)

  • 1. Pathophysiology of IBD associated diarrhea.
    Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
    Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
    Priyamvada S; Gomes R; Gill RK; Saksena S; Alrefai WA; Dudeja PK
    Inflamm Bowel Dis; 2015 Dec; 21(12):2926-35. PubMed ID: 26595422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea.
    Sullivan S; Alex P; Dassopoulos T; Zachos NC; Iacobuzio-Donahue C; Donowitz M; Brant SR; Cuffari C; Harris ML; Datta LW; Conklin L; Chen Y; Li X
    Inflamm Bowel Dis; 2009 Feb; 15(2):261-74. PubMed ID: 18942765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of disrupted intestinal barrier in inflammatory bowel diseases.
    Salim SY; Söderholm JD
    Inflamm Bowel Dis; 2011 Jan; 17(1):362-81. PubMed ID: 20725949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of epithelial ion transports in inflammatory bowel disease.
    Magalhães D; Cabral JM; Soares-da-Silva P; Magro F
    Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G460-76. PubMed ID: 26744474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Diseases of the Gut.
    Rohr M; Narasimhulu CA; Sharma D; Doomra M; Riad A; Naser S; Parthasarathy S
    J Med Food; 2018 Feb; 21(2):113-126. PubMed ID: 29389238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
    Schlegel N; Boerner K; Waschke J
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular insights into inflammatory bowel disease-induced diarrhea.
    Tang Y; Forsyth CB; Keshavarzian A
    Expert Rev Gastroenterol Hepatol; 2011 Oct; 5(5):615-25. PubMed ID: 21910579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of diarrhea in inflammatory bowel diseases.
    Binder HJ
    Ann N Y Acad Sci; 2009 May; 1165():285-93. PubMed ID: 19538318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of diarrhea.
    Surawicz CM
    Curr Gastroenterol Rep; 2010 Aug; 12(4):236-41. PubMed ID: 20532705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population.
    Bianchi L; Gaiani F; Bizzarri B; Minelli R; Cortegoso Valdivia P; Leandro G; Di Mario F; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):76-80. PubMed ID: 30561398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and inflammatory bowel disease.
    Cummins EP; Crean D
    Microbes Infect; 2017 Mar; 19(3):210-221. PubMed ID: 27664046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.
    Sobczak M; Fabisiak A; Murawska N; Wesołowska E; Wierzbicka P; Wlazłowski M; Wójcikowska M; Zatorski H; Zwolińska M; Fichna J
    Pharmacol Rep; 2014 Oct; 66(5):766-75. PubMed ID: 25149979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.
    Goyette P; Labbé C; Trinh TT; Xavier RJ; Rioux JD
    Ann Med; 2007; 39(3):177-99. PubMed ID: 17457716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of diarrhea in collagenous colitis.
    Bürgel N; Bojarski C; Mankertz J; Zeitz M; Fromm M; Schulzke JD
    Gastroenterology; 2002 Aug; 123(2):433-43. PubMed ID: 12145796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
    Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.